ANI Pharmaceuticals Inc
ANIPNasdaqCIK 1023024HealthcareFiscal year ends Dec 31
Reports and events: 380 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2407:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001023024-26-000071 |
| 2026-08-0707:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001023024-26-000069 |
| 2026-08-0707:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-26-000068 |
| 2026-05-2116:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001023024-26-000056 |
| 2026-05-1308:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-26-000054 |
| 2026-05-0806:58 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001023024-26-000050 |
| 2026-05-0806:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-26-000049 |
| 2026-04-0916:12 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001023024-26-000039 |
| 2026-04-0716:21 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001023024-26-000034 |
| 2026-03-0307:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-26-000017 |
| 2026-02-2706:59 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001023024-26-000014 |
| 2026-02-2706:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-26-000013 |
| 2026-01-1216:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-26-000005 |
| 2025-12-0106:58 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000113 |
| 2025-11-1008:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000110 |
| 2025-11-0706:57 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001023024-25-000108 |
| 2025-11-0706:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-25-000107 |
| 2025-09-2617:03 ET | 8-K | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights | 0001023024-25-000099 |
| 2025-09-0806:57 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000089 |
| 2025-08-2208:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-081631 |
| 2025-08-0807:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001023024-25-000082 |
| 2025-08-0806:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-25-000081 |
| 2025-07-2916:55 ET | 8-K | 8.01 Other events | 0001104659-25-071769 |
| 2025-07-2316:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001023024-25-000074 |
| 2025-07-2306:53 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001023024-25-000072 |
| 2025-06-0407:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000058 |
| 2025-05-2307:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001023024-25-000056 |
| 2025-05-2008:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000049 |
| 2025-05-0906:57 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001023024-25-000046 |
| 2025-05-0906:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-25-000044 |
| 2025-05-0809:14 ET | 8-K | 8.01 Other events | 0001104659-25-045937 |
| 2025-04-1016:38 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001023024-25-000035 |
| 2025-03-1807:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001023024-25-000024 |
| 2025-03-1416:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001023024-25-000021 |
| 2025-03-1320:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-023609 |
| 2025-03-1107:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000018 |
| 2025-02-2807:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001023024-25-000015 |
| 2025-02-2806:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-25-000012 |
| 2025-02-0507:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000006 |
| 2025-01-1307:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000002 |
| 2024-11-2007:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-24-000106 |
| 2024-11-0808:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001023024-24-000102 |
| 2024-11-0806:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-24-000100 |
| 2024-09-2016:03 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001023024-24-000093 |
| 2024-09-1609:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001023024-24-000088 |
| 2024-08-1316:21 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-24-012144 |
| 2024-08-0821:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-24-011897 |
| 2024-08-0707:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-24-011822 |
| 2024-08-0606:57 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001023024-24-000085 |
| 2024-08-0606:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-24-000083 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:45 ET. Listed shows no prices and gives no investment advice.